Mitoxantrone Hydrochloride Liposome Injection-containing Bridging Regimen and CD19-targeting CAR-T Therapies
ACTIVE_NOT_RECRUITING
Status
Conditions
- B-cell Acute Lymphoblastic Leukemia
- B-cell Lymphoma Refractory
Interventions
- DRUG: Mitoxantrone hydrochloride liposome Injection-based bridging therapy+ Fludarabine-based chemotherapy +CD19 CAR-T Cells
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Collaborators